These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27272725)

  • 1. Adaptive responses to cefotaxime treatment in ESBL-producing Escherichia coli and the possible use of significantly regulated pathways as novel secondary targets.
    Møller TS; Rau MH; Bonde CS; Sommer MO; Guardabassi L; Olsen JE
    J Antimicrob Chemother; 2016 Sep; 71(9):2449-59. PubMed ID: 27272725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTX-M-1 β-lactamase expression in Escherichia coli is dependent on cefotaxime concentration, growth phase and gene location.
    Kjeldsen TS; Overgaard M; Nielsen SS; Bortolaia V; Jelsbak L; Sommer M; Guardabassi L; Olsen JE
    J Antimicrob Chemother; 2015 Jan; 70(1):62-70. PubMed ID: 25182062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain.
    Castellanos LR; Donado-Godoy P; León M; Clavijo V; Arevalo A; Bernal JF; Timmerman AJ; Mevius DJ; Wagenaar JA; Hordijk J
    PLoS One; 2017; 12(1):e0170777. PubMed ID: 28125687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended spectrum β-lactamase-producing Escherichia coli forms filaments as an initial response to cefotaxime treatment.
    Kjeldsen TS; Sommer MO; Olsen JE
    BMC Microbiol; 2015 Mar; 15():63. PubMed ID: 25888392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global gene expression profiling and antibiotic susceptibility after repeated exposure to the carbon monoxide-releasing molecule-2 (CORM-2) in multidrug-resistant ESBL-producing uropathogenic Escherichia coli.
    Sahlberg Bang C; Demirel I; Kruse R; Persson K
    PLoS One; 2017; 12(6):e0178541. PubMed ID: 28591134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and Molecular Characterization of Escherichia coli Strains Producers of Extended-Spectrum and CMY-2 Type Beta-Lactamases, Isolated from Turtles in Mexico.
    Cortés-Cortés G; Lozano-Zarain P; Torres C; Castañeda M; Sánchez GM; Alonso CA; López-Pliego L; Mayen MG; Martínez-Laguna Y; Rocha-Gracia Rdel C
    Vector Borne Zoonotic Dis; 2016 Sep; 16(9):595-603. PubMed ID: 27482752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
    Tian GB; Huang YM; Fang ZL; Qing Y; Zhang XF; Huang X
    J Antimicrob Chemother; 2014 Aug; 69(8):2081-5. PubMed ID: 24777903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
    Hasan B; Laurell K; Rakib MM; Ahlstedt E; Hernandez J; Caceres M; Järhult JD
    Microb Drug Resist; 2016 Dec; 22(8):682-687. PubMed ID: 27007258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.
    Alcalá L; Alonso CA; Simón C; González-Esteban C; Orós J; Rezusta A; Ortega C; Torres C
    Microb Ecol; 2016 Nov; 72(4):861-869. PubMed ID: 26687342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-mediated resistance to cephalosporins and quinolones in Escherichia coli from American crows in the USA.
    Jamborova I; Dolejska M; Zurek L; Townsend AK; Clark AB; Ellis JC; Papousek I; Cizek A; Literak I
    Environ Microbiol; 2017 May; 19(5):2025-2036. PubMed ID: 28276133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and characterisation of ESBL-encoding plasmids among Escherichia coli isolates from fresh vegetables.
    Freitag C; Michael GB; Li J; Kadlec K; Wang Y; Hassel M; Schwarz S
    Vet Microbiol; 2018 Jun; 219():63-69. PubMed ID: 29778206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephem Potentiation by Inactivation of Nonessential Genes Involved in Cell Wall Biogenesis of β-Lactamase-Producing Escherichia coli.
    Baker KR; Sigurðardóttir HH; Jana B; Guardabassi L
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø
    Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
    Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.